How is Prostate cancer diagnosed?

['Deungoen halaman nyoe']

Pakriban cara geu diagnosa kanker prostat?

Kanker prostat didiagnosis melalui kombinasi tes ngon prosedur, yang jeut mencakup:

1. Pemeriksaan Rektum Digital (DRE): Dokter peutamong jaroe nyang jimat sarung jaroe, dan dilumasi u dalam rektum untuk meurasa prostat na kelainan.

2. Tes Prostate-Specific Antigen (PSA): nyo adalah tes darah nyang ji uko tingkat PSA, protein nyang ji produksi le kelenjar prostat.

Tingkat PSA nyang ji ek jeut geu indikasi na kanker prostat.

3. Transrectal Ultrasound (TRUS): Saboh probe ubit ji peutameng u dalam rektum untuk ji peuget gamba prostat nyang ji pakek gelombang su.

Nyo jeut membantu geuidentifikasi na kelainan bak kelenjar prostat.

4. Biopsi: Saboh sampel ubit jaringan prostat dicok dan diteuliti deungen mikroskop untuk na sel kanker.

Nyo keuh saboh-saboh jih cara definitif untuk didiagnosis kanker prostat.

5. Magnetic Resonance Imaging (MRI): Scan MRI prostat jeut membantu mengidentifikasi kelainan dan memandu prosedur biopsi.

6. Pengujian Genomik: Padum-padum droe dokter jeut geu pakek tes genomik untuk geubantu geu peuteunte tingkat agresif kanker ngon geu bimbeng keputusan perawatan.

7. Bone Scan: Scan tuleung jeut dilakukan untuk memeriksa peu kanker ka menyebar ke tuleung.

8. Computed Tomography (CT) Scan: CT scan jeut dipakek untuk geu cek peu kanker ka menyebar ke organ atau jaringan laen.

Penting untuk taingat bahwa ken mandum ureung agam yang na tingkat PSA yang tinggi atau hasil DRE yang abnormal akan na kanker prostat, dan ken mandum kanker prostat akan menyebabkan tingkat PSA yang tinggi.

Oleh karena nyan, biopsi perle untuk geu konfirmasi diagnosis.

Seulaen nyan, keputusan untuk menjalani biopsi dipeuget lheuh dipeutimbangkan hasee tes nyo dan faktor risiko dan pilihan individu.

['Referensi[peusaneut nè]']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM: Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology. 2011, 21 (2): 195-205.

Marenco J, Kasivisvanathan V, Emberton M: New standards in prostate biopsy. Arch Esp Urol. 2019, 72 (2): 142-149.

Moradi M, Mousavi P, Abolmaesumi P: Computer-aided diagnosis of prostate cancer with emphasis on ultrasound-based approaches: a review. Ultrasound Med Biol. 2007, 33 (7): 1010-28.

Cuperlovic-Culf M, Belacel N, Davey M, Ouellette RJ: Multi-gene biomarker panel for reference free prostate cancer diagnosis: determination and independent validation. Biomarkers. 2010, 15 (8): 693-706.

McGrath SE, Michael A, Morgan R, Pandha H: EN2: a novel prostate cancer biomarker. Biomark Med. 2013, 7 (6): 893-901.

An Y, Chang W, Wang W, Wu H, Pu K, Wu A, Qin Z, Tao Y, Yue Z, Wang P, Wang Z: A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells. J Adv Res. 2020, 24 (): 363-370.

[Consensus of Chinese experts on the application of molecular imaging targeting prostate specific membrane antigen in prostate cancer patients]. Zhonghua Wai Ke Za Zhi. 2018, 56 (2): 91-94.

Zhong WD, He HC, Bi XC, Ou RB, Jiang SA, Liu LS: cDNA macroarray for analysis of gene expression profiles in prostate cancer. Chin Med J (Engl). 2006, 119 (7): 570-3.

['Peuneugah: medis']

['Situs web nyoe hanya dipeutaba untuk tujuan pendidikan dan informasi dan hana merupakan nasehat medis atau layanan profesional.']

['Informasi nyang geubri hana jeut dipakek untuk mendiagnosis atau meuobati masalah kesehatan atau peunyaket, dan awak nyang mita nasehat medis pribadi harus berkonsultasi deungen dokter berlisensi.']

['Neuronal net nyang ji peuhase jawaban keu pertanyaan, khusus jih hana akurat wate ji peugah tentang konten numerik. miseu jih, jumlah ureung nyang ji diagnosa deungen peunyaket tertentu.']

['Sabe-sabe mita saran dari dokter atau penyedia kesehatan laen nyang berkualitas teuntang kondisi medis. Han tom neutilek nasihat medis profesional atawa neuterlambat mita jih kareuna na sesuatu nyang kaleuh neubaca bak situs web nyoe. Meunyo droeneuh pike droeneuh na darurat medis, hubungi 911 atawa neujak u ruang gawat darurat paleng toe langsong. Hana hubungan dokter-pasien nyang dipeuget le situs web nyoe atawa penggunaan jih. BioMedLib maupun karyawan jih, atawa kontributor situs web nyoe, hana dipeuget representasi, nyata atawa tersirat, teuntang informasi nyang geubri disinoe atawa penggunaan jih.']

['Peuneugah: hak cipta']

['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) geubi recourse keu ureung po hak cipta nyang yakin bahwa materi nyang deuh bak internet ji langgar hak awak nyan di miyup undang-undang hak cipta AS. ']

['Meunyo droeneuh yakin ngon get bahwa asoe atawa bahan nyang geupeutamöng lam hubôngan ngon website atawa layanan kamoe meulangga hak cipta droeneuh, droeneuh (atawa agen droeneuh) jeuet neukirém beuneuri keu kamoe ngön neulakèe mangat asoe atawa bahan nyan geusampôh, atawa geupeublok akses keujih.']

['Peumaklum haroh dikirim seucara tuleh deungen email (nging bagian "Kontak" untuk alamat email).']

['DMCA peurlee bahwa bewara droeneuh teuntang dugaan pelanggaran hak cipta teumasok informasi berikut: (1) deskripsi karya yang dilindungi hak cipta yang merupakan subjek klaim pelanggaran; (2) deskripsi konten yang diduga melanggar dan informasi yang cukup untuk memungkinkan kamoe untuk meutumeng konten; (3) informasi kontak untuk droeneuh, termasuk alamat, nomor telepon dan alamat email droeneuh; (4) pernyataan droeneuh bahwa droeneuh yakin bahwa konten yang diklaim hana diizinkan le pemilik hak cipta, atau agen jih, atau oleh operasi hukum apapun; ']

['(5) saboh pernyataan dari droeneuh, yang diteken deungen hukuman sumpah palsu, bahwa informasi lam pemberitahuan nyan akurat dan bahwa droeneuh na wewenang untuk menegakkan hak cipta yang diklaim dilanggar;']

['dan (6) tanda jaroe fisik atawa elektronik dari nyang po hak cipta atawa sidroe ureng nyang berwenang untuk bertindak atas nama nyang po hak cipta. ']

['Meunye hana neupeutamong mandum informasi di ateuh jeut keu akibat teulat meungurus keluhan droeneuh.']

['Kontak']

['Neukirem kheueh email keukamoe ateuh peue-peue nyang neutanyong atawa saran.']

How is prostate cancer diagnosed?

Prostate cancer is diagnosed through a combination of tests and procedures, which may include:

1. Digital Rectal Exam (DRE): A doctor inserts a gloved, lubricated finger into the rectum to feel the prostate for any abnormalities.

2. Prostate-Specific Antigen (PSA) Test: This is a blood test that measures the level of PSA, a protein produced by the prostate gland.

Elevated PSA levels may indicate the presence of prostate cancer.

3. Transrectal Ultrasound (TRUS): A small probe is inserted into the rectum to create an image of the prostate using sound waves.

This can help identify any abnormalities in the prostate gland.

4. Biopsy: A small sample of prostate tissue is removed and examined under a microscope for the presence of cancer cells.

This is the only definitive way to diagnose prostate cancer.

5. Magnetic Resonance Imaging (MRI): An MRI scan of the prostate can help identify any abnormalities and guide the biopsy procedure.

6. Genomic Testing: Some doctors may use genomic tests to help determine the aggressiveness of the cancer and guide treatment decisions.

7. Bone Scan: A bone scan may be performed to check if the cancer has spread to the bones.

8. Computed Tomography (CT) Scan: A CT scan may be used to check if the cancer has spread to other organs or tissues.

It is important to note that not all men with elevated PSA levels or abnormal DRE results will have prostate cancer, and not all prostate cancers will cause elevated PSA levels.

Therefore, a biopsy is necessary to confirm the diagnosis.

Additionally, the decision to undergo a biopsy is made after considering the results of these tests and the individual's risk factors and preferences.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.